posted on
Dec 31, 2011 08:36PM

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Message: Re: T3 - What do you think is the endgame?
One possibility is that TPL, having built up cash assets via its CORE portfolio and maybe one or two "lesser" MMP deals, could acquire PTSC for 10c-15c (i.e. 2x to 3x current market value). At 10c a share that's $41M to find
Another possibility would be for TPL to merge into PTSC and take advantage of PTSC's tax loss carry-forward (which I haven't researched). This might be of benefit to PTSC shareholders IF the deal is structured to that end.
Either way puts MMP ownership in one place and strengthens the leverage against alleged infringers. It also eliminates the PTSC/PDS/TPL bickering (and extravagances) and may placate Chuck Moore. I can see how that would be the ultimate goal.
Loading...
Loading...
1
Jan 02, 2012 11:58AM
1
Jan 02, 2012 09:59PM
New Message
Please
login
to post a reply